Skip to main content
Swing Capital

Concord Biotech Ltd

NSE: CONCORDBIO BSE: 543960

Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology.[1]

₹1,114
52W: ₹987 — ₹2150
PE 36.8 · Book ₹174 · +540% vs book
Market Cap₹11,660 Cr
Stock P/E36.8Price to Earnings
ROCE28.4%Return on Capital
ROE21.4%Return on Equity
Div. Yield0.95%Face Value ₹1

Strengths

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Company has delivered good profit growth of 18.7% CAGR over last 5 years
  • +Company has been maintaining a healthy dividend payout of 28.2%

Weaknesses

  • −Company has high debtors of 159 days.

Shareholding Pattern

Promoters44.08%
FIIs7.79%
DIIs9.22%
Public38.9%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters44.08%44.08%44.08%44.08%44.08%44.08%44.08%44.08%
FIIs7.11%8.1%▲1.08.33%▲0.29.35%▲1.09.1%▼0.38.03%▼1.17.58%▼0.47.79%▲0.2
DIIs10.35%9.89%▼0.59.65%▼0.29.16%▼0.58.85%▼0.39.55%▲0.79.58%▲0.09.22%▼0.4
Public38.46%37.95%▼0.537.93%▼0.037.41%▼0.537.94%▲0.538.32%▲0.438.75%▲0.438.9%▲0.1

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales262241319216310244430204247278
Expenses143135185135174146239143157176
Operating Profit11910613481137981906191102
OPM %45%44%42%38%44%40%44%30%37%37%
Net Profit847597589974142436368
EPS ₹8.087.139.295.579.437.0813.574.076.016.48

AI Insights

Revenue Trend

TTM revenue at ₹1,159Cr, down 3.4% YoY. OPM at 38%.

Debt Position

Borrowings at ₹2Cr. Debt-to-equity ratio: 0.00x. Healthy balance sheet.

Capex Cycle

CWIP at ₹74Cr (9% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 9.22% (+1.10pp change). FIIs: 7.79% (+0.49pp change). Promoters hold 44.08%.

Margin & Efficiency

ROCE improving from 0% (Mar 2015) to 28% (Mar 2025). Working capital days: 193.

Valuation

PE 36.8x with 28.4% ROCE. Price is 540% above book value of ₹174. Dividend yield: 0.95%.

Recent Announcements